The Resource ACEi and ARBS in hypertension and heart failure, Pasquale Perrone Filardi, editor

ACEi and ARBS in hypertension and heart failure, Pasquale Perrone Filardi, editor

Label
ACEi and ARBS in hypertension and heart failure
Title
ACEi and ARBS in hypertension and heart failure
Statement of responsibility
Pasquale Perrone Filardi, editor
Contributor
Editor
Subject
Genre
Language
eng
Summary
The renin angiotensin system is implicated in the progression of atherosclerotic disease as well as of left ventricular dysfunction. Angiotensin converting enzyme inhibitors and AT1 receptor antagonists have been proven to reduce morbidity and mortality in patients with left ventricular dysfunction or in those at high cardiovascular risk with preserved ventricular function. This book is intended to summarize evidences and provide a rationale for the appropriate use of RAS antagonists in cardiovascular diseases. It will be presented as highly practical information on this topic
Member of
Cataloging source
GW5XE
Dewey number
616.1206
Illustrations
illustrations
Index
index present
LC call number
RC684.A53
LC item number
A23 2015eb
Literary form
non fiction
Nature of contents
dictionaries
http://library.link/vocab/relatedWorkOrContributorName
Filardi, Pasquale Perrone
Series statement
Current Cardiovascular Therapy
Series volume
5
http://library.link/vocab/subjectName
  • Angiotensin converting enzyme
  • Hypertension
  • Heart failure
  • HEALTH & FITNESS
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • MEDICAL
  • Angiotensin converting enzyme
  • Heart failure
  • Hypertension
Label
ACEi and ARBS in hypertension and heart failure, Pasquale Perrone Filardi, editor
Link
https://ezproxy.lib.ou.edu/login?url=http://link.springer.com/10.1007/978-3-319-09788-6
Instantiates
Publication
Copyright
Note
Includes index
Antecedent source
unknown
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Preface; Contents; Contributors; Chapter 1: Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension; RAS Inhibition and Blood Pressure Lowering; RAS Inhibition and Hypertension-Related Metabolic Abnormalities; Dyslipidemias; Metabolic Syndrome and Obesity; Insulin Resistance and Diabetes; RAS Inhibition and Hypertension-Related TOD; Left Ventricular Hypertrophy; Chronic Kidney Disease; Dual RAS Inhibition; Atherosclerosis; RAS Inhibition and CV Events; Stroke; Myocardial Infarction; RAS Inhibitors and Mortality; References
  • Chapter 2: ACE Inhibitor and Renin-Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure; Definition of Heart Failure; Epidemiology, Incidence, Prevalence and Natural History of Heart Failure; Aetiology of Heart Failure; Pathophysiology of Heart Failure; The Renin-Angiotensin System; Focus on Blockade of the Renin-Angiotensin System; Trials That Support the Use of Angiotensing-Converting Enzyme Inhibitors; ACE-Inhibitors Compared with Angiotensin Receptor Blockers; Use of the ACE Inhibitors in the Hearth Failure: ESC and ACCF/AHA Guidelines; References
  • Chapter 3: Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System-Inhibitors in Patients with Hypertension and Heart Failure; Introduction; Choice of RAAS Inhibitors in Patients with Chronic Kidney Disease; Studies in Diabetic or Non-diabetic Proteinuric Kidney Disease; Studies in Non-proteinuric Kidney Disease; High Doses of RAAS-Inhibitors or Dual RAAS Blockade; Choice of Antihypertensive Treatment in Patients with Diabetes Mellitus; Effects of Antihypertensive Agents on Insulin Sensitivity; Effects of Antihypertensive Agents on New-Onset DM
  • Data from Hypertension Outcome Trials Evaluating New-Onset DM as a Secondary Outcome; Data from Trials and Meta-analyses Investigating the Effects of Antihypertensive Agents on Metabolic Parameters and New-Onset DM; New-Onset DM and Cardiovascular Risk; Conclusion; References; Chapter 4: Target Organ Damage and RAAS Blockade; Introduction; RAAS Dysregulation and Target Organ Damage; Monotherapy with ACEIs; Monotherapy with ARBs; Dual Therapy; Comparison Between ACEIs and ARBs; Conclusions; References; Index
Dimensions
unknown
Extent
1 online resource (x, 150 pages)
File format
unknown
Form of item
online
Isbn
9783319097886
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Note
SpringerLink
Other control number
10.1007/978-3-319-09788-6
Other physical details
illustrations (some color).
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
  • (OCoLC)894348203
  • (OCoLC)ocn894348203
Label
ACEi and ARBS in hypertension and heart failure, Pasquale Perrone Filardi, editor
Link
https://ezproxy.lib.ou.edu/login?url=http://link.springer.com/10.1007/978-3-319-09788-6
Publication
Copyright
Note
Includes index
Antecedent source
unknown
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
multicolored
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
  • Preface; Contents; Contributors; Chapter 1: Angiotensin Converting Enzyme Inhibitors and AT1 Antagonists for Treatment of Hypertension; RAS Inhibition and Blood Pressure Lowering; RAS Inhibition and Hypertension-Related Metabolic Abnormalities; Dyslipidemias; Metabolic Syndrome and Obesity; Insulin Resistance and Diabetes; RAS Inhibition and Hypertension-Related TOD; Left Ventricular Hypertrophy; Chronic Kidney Disease; Dual RAS Inhibition; Atherosclerosis; RAS Inhibition and CV Events; Stroke; Myocardial Infarction; RAS Inhibitors and Mortality; References
  • Chapter 2: ACE Inhibitor and Renin-Angiotensin System the Cornerstone of Therapy for Systolic Heart Failure; Definition of Heart Failure; Epidemiology, Incidence, Prevalence and Natural History of Heart Failure; Aetiology of Heart Failure; Pathophysiology of Heart Failure; The Renin-Angiotensin System; Focus on Blockade of the Renin-Angiotensin System; Trials That Support the Use of Angiotensing-Converting Enzyme Inhibitors; ACE-Inhibitors Compared with Angiotensin Receptor Blockers; Use of the ACE Inhibitors in the Hearth Failure: ESC and ACCF/AHA Guidelines; References
  • Chapter 3: Impact of Chronic Kidney Disease and Diabetes Mellitus on Choice of Renin Angiotensin System-Inhibitors in Patients with Hypertension and Heart Failure; Introduction; Choice of RAAS Inhibitors in Patients with Chronic Kidney Disease; Studies in Diabetic or Non-diabetic Proteinuric Kidney Disease; Studies in Non-proteinuric Kidney Disease; High Doses of RAAS-Inhibitors or Dual RAAS Blockade; Choice of Antihypertensive Treatment in Patients with Diabetes Mellitus; Effects of Antihypertensive Agents on Insulin Sensitivity; Effects of Antihypertensive Agents on New-Onset DM
  • Data from Hypertension Outcome Trials Evaluating New-Onset DM as a Secondary Outcome; Data from Trials and Meta-analyses Investigating the Effects of Antihypertensive Agents on Metabolic Parameters and New-Onset DM; New-Onset DM and Cardiovascular Risk; Conclusion; References; Chapter 4: Target Organ Damage and RAAS Blockade; Introduction; RAAS Dysregulation and Target Organ Damage; Monotherapy with ACEIs; Monotherapy with ARBs; Dual Therapy; Comparison Between ACEIs and ARBs; Conclusions; References; Index
Dimensions
unknown
Extent
1 online resource (x, 150 pages)
File format
unknown
Form of item
online
Isbn
9783319097886
Level of compression
unknown
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Note
SpringerLink
Other control number
10.1007/978-3-319-09788-6
Other physical details
illustrations (some color).
Quality assurance targets
not applicable
Reformatting quality
unknown
Sound
unknown sound
Specific material designation
remote
System control number
  • (OCoLC)894348203
  • (OCoLC)ocn894348203

Library Locations

  • Architecture LibraryBorrow it
    Gould Hall 830 Van Vleet Oval Rm. 105, Norman, OK, 73019, US
    35.205706 -97.445050
  • Bizzell Memorial LibraryBorrow it
    401 W. Brooks St., Norman, OK, 73019, US
    35.207487 -97.447906
  • Boorstin CollectionBorrow it
    401 W. Brooks St., Norman, OK, 73019, US
    35.207487 -97.447906
  • Chinese Literature Translation ArchiveBorrow it
    401 W. Brooks St., RM 414, Norman, OK, 73019, US
    35.207487 -97.447906
  • Engineering LibraryBorrow it
    Felgar Hall 865 Asp Avenue, Rm. 222, Norman, OK, 73019, US
    35.205706 -97.445050
  • Fine Arts LibraryBorrow it
    Catlett Music Center 500 West Boyd Street, Rm. 20, Norman, OK, 73019, US
    35.210371 -97.448244
  • Harry W. Bass Business History CollectionBorrow it
    401 W. Brooks St., Rm. 521NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • History of Science CollectionsBorrow it
    401 W. Brooks St., Rm. 521NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • John and Mary Nichols Rare Books and Special CollectionsBorrow it
    401 W. Brooks St., Rm. 509NW, Norman, OK, 73019, US
    35.207487 -97.447906
  • Library Service CenterBorrow it
    2601 Technology Place, Norman, OK, 73019, US
    35.185561 -97.398361
  • Price College Digital LibraryBorrow it
    Adams Hall 102 307 West Brooks St., Norman, OK, 73019, US
    35.210371 -97.448244
  • Western History CollectionsBorrow it
    Monnet Hall 630 Parrington Oval, Rm. 300, Norman, OK, 73019, US
    35.209584 -97.445414
Processing Feedback ...